Literature DB >> 6423323

Biochemical studies on the purine metabolism of four cases with hereditary xanthinuria.

T Kojima, T Nishina, M Kitamura, T Hosoya, K Nishioka.   

Abstract

The purine metabolism of four cases with marked hypouricemia (serum uric acid concentration of less than 0.018 mmol/l) from three Japanese families was investigated. Erythrocyte adenosine deaminase (EC 3.5.4.4) and purine-nucleoside phosphorylase (EC 2.4.2.1) activities of the patients were within the normal ranges. Urinary hypoxanthine and xanthine concentrations were 0.096-0.397 mmol/l and 0.743-1.717 mmol/l, respectively. Xanthine oxidase (EC 1.2.3.2) activities in the jejunal mucosa of the two normal controls were 0.257 and 0.283 units/g protein, while those of three of the patients were extremely low and could not be determined. The findings of these biochemical features may indicate that the four patients have hereditary xanthinuria. In order to study the purine metabolism in the hypouricemic condition of this disorder, a single oral dose of allopurinol (4-hydroxypyrazolo[3,4-d]pyrimidine) was administered in one case. The excretion pattern of allopurinol and oxypurinol (4,6-dihydroxypyrazolo[3,4-d]pyrimidine) in the urine of the patient was similar to that of a normal control male. These data suggest that some residual enzyme activity may be functioning in vivo, although the presence of xanthine oxidase could not be detected.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6423323     DOI: 10.1016/0009-8981(84)90179-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  A case of xanthinuria type I with a novel mutation in xanthine dehydrogenase.

Authors:  Akira Iguchi; Takaaki Sato; Mihoko Yamazaki; Kazuyuki Tasaki; Yasushi Suzuki; Noriaki Iino; Hiroshi Hasegawa; Kimiyoshi Ichida; Ichiei Narita
Journal:  CEN Case Rep       Date:  2016-03-03

2.  Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria.

Authors:  K Ichida; Y Amaya; N Kamatani; T Nishino; T Hosoya; O Sakai
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

3.  Hereditary xanthinuria. Evidence for enhanced hypoxanthine salvage.

Authors:  F A Mateos; J G Puig; M L Jiménez; I H Fox
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

4.  Differential regulation of hypoxanthine and xanthine by obesity in a general population.

Authors:  Masato Furuhashi; Masayuki Koyama; Yukimura Higashiura; Takayo Murase; Takashi Nakamura; Megumi Matsumoto; Akiko Sakai; Hirofumi Ohnishi; Marenao Tanaka; Shigeyuki Saitoh; Norihito Moniwa; Kazuaki Shimamoto; Tetsuji Miura
Journal:  J Diabetes Investig       Date:  2020-02-09       Impact factor: 4.232

5.  The effect of dietary protein restriction in a case of molybdenum cofactor deficiency with MOCS1 mutation.

Authors:  Yu Abe; Yu Aihara; Wakaba Endo; Hiroshi Hasegawa; Kimiyoshi Ichida; Mitsugu Uematsu; Shigeo Kure
Journal:  Mol Genet Metab Rep       Date:  2021-02-01

6.  Xanthinuria Type 1 with a Novel Mutation in Xanthine Dehydrogenase and a Normal Endothelial Function.

Authors:  Satoshi Miyazaki; Toshihiro Hamada; Shinobu Sugihara; Einosuke Mizuta; Yusuke Endo; Akira Ohtahara; Koji Komatsu; Masanari Kuwabara; Tomoko Fukuuchi; Kiyoko Kaneko; Kimiyoshi Ichida; Kazuhide Ogino; Haruaki Ninomiya; Kazuhiro Yamamoto; Takashi Nakamura; Ichiro Hisatome
Journal:  Intern Med       Date:  2022-05-01       Impact factor: 1.282

Review 7.  Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans.

Authors:  Kimiyoshi Ichida; Yoshihiro Amaya; Ken Okamoto; Takeshi Nishino
Journal:  Int J Mol Sci       Date:  2012-11-21       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.